Jun. 24 at 10:05 PM
$MGNX A liquidity-driven short squeeze is beginning to play out, triggered by fundamental news.The Catalyst: On June 23, Sanofi triggered a
$24.5 million milestone payment to MacroGenics. In the biotech sector, an unexpected injection of non-dilutive cash completely changes a company's runway.The Trap: As shown in the 6-month trend, shorts have been steadily building a position since January, increasing shorted shares from 3.5M to nearly 5M. They assumed the stock would break downward due to earlier pipeline setbacks.The Squeeze Mechanics: When the Sanofi news broke, massive buying volume flooded the stock, driving it to a 52-week high of
$5.08.DAYS to Cover Risk: Because it takes over 5 days for shorts to fully buy back their shares under normal liquidity conditions, they cannot escape quickly. The 2-million-share volume days we are seeing right now are a mix of new retail investors buying the momentum and panicked short sellers forced to buy
